Anti-CD19 and anti-CD22 monoclonal antibodies increase the effectiveness of chemotherapy in Pre-B acute lymphoblastic leukemia cell lines.

Source:http://linkedlifedata.com/resource/pubmed/id/17706771

Download in:

View as

General Info

PMID
17706771